AMGN
Amgen Inc.
- Free cash flow, 2025
- $8.1B
- YoY, 2025
- −22.1%
- 5-year CAGR
- −3.9%
- 10-year CAGR
- −1.2%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $8.1B | −22.1% |
| 2024 | $10.4B | +41.2% |
| 2023 | $7.4B | −16.2% |
| 2022 | $8.8B | +4.8% |
| 2021 | $8.4B | −15.2% |
| 2020 | $9.9B | +15.9% |
| 2019 | $8.5B | −19.2% |
| 2018 | $10.6B | +0.4% |
| 2017 | $10.5B | +9.3% |
| 2016 | $9.6B | +5.2% |
| 2015 | $9.1B | +11.0% |
| 2014 | $8.2B | +47.1% |
| 2013 | $5.6B | +7.8% |
| 2012 | $5.2B | +14.1% |
| 2011 | $4.6B | −12.6% |
| 2010 | $5.2B | −10.3% |
| 2009 | $5.8B | +9.2% |
| 2008 | $5.3B | +28.6% |
| 2007 | $4.1B | — |